Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 794

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 794
---
 to have notice of and consented to the provisions of this Article VIII.

<div align='center'>Article IX

AMENDMENTS</div>

Notwithstanding any other provisions
of this Amended and Restated Certificate or any provision of law which might otherwise permit a lesser vote or no vote, but in addition
to any affirmative vote of the holders of any particular class or series of the Voting Stock required by law or by this Amended and Restated
Certificate (including any Certificate of Designation in respect of one or more series of Preferred Stock), the affirmative vote of the
holders of at least sixty-six and two-thirds percent (66-2/3%) of the voting power of all of the then-outstanding shares of the Voting
Stock, voting together as a single class, shall be required to alter, amend or repeal Articles V, VI, VII and VIII and this Article IX.

| B-7 |

THIS CERTIFICATE OF INCORPORATION is executed as of this [__] day of [__],
2025.

| Futuretech          
 II Acquisition Corp |
| By:                 |
| Name:               |
| Title:              |

ANNEX C

<div align='center'>SPONSOR SUPPORT AGREEMENT</div>

This SPONSOR SUPPORT AGREEMENT (this “ Agreement”) is entered into as of September 16, 2024, by and among Longevity Biomedical, Inc., a Delaware corporation (the “ Company”), FutureTech II Acquisition Corp., a Delaware corporation (the “ Purchaser”), and FutureTech Partners II LLC, a Delaware limited liability company (the “ Sponsor”). The Company and the Sponsor are sometimes referred to herein as a “ Party” and collectively as the “ Parties”.

<div align='center'>WITNESSETH:</div>

WHEREAS, as of the date hereof, the Sponsor “ beneficially owns” (as such term is defined in Rule 13d-3 promulgated under the Exchange Act) and is entitled to dispose of (or to direct the disposition of) and to vote (or to direct the voting of) the number of shares of Class A common stock, par value $0.0001 (the “ Purchaser Class A Common Stock”) and the number of shares of Class B common stock, par value $0.0001 per share (the “ Purchaser Class B Common Stock”), of the Purchaser set forth opposite its name on Schedule Ihereto (such shares of Purchaser Class A Common Stock and Purchaser Class B Common Stock